In-Depth

The In-Depth page consists of Insight Articles, Commentaries, C-level Q&As, Discussion Group Reports, and Survey Reports.

Insight Article
mRNA took a long time to come to fruition, but recent advancements has enabled production at a never seen before scale.
By Oliver Picken |
06 May 2022
RNA Formulation & Delivery
Insight Article
Despite their advantages, combination products present new technological and organizational challenges. They require new product development strategies compared to standalone products, drugs, and devices.
By Oliver Picken |
05 May 2022
Drug Delivery
Discussion Group Report
While new manufacturing technologies have the potentially to dramatically shift the way the pharmaceutical industry works, many challenges are preventing wider adoption.
By Oliver Picken |
27 April 2022
Drug Formulation
Commentary
In this commentary article, we present Axel Becker's insights on the latest techniques governing API particle properties and the processes that dictate the success of drug reception and tablet compression.
By Ben Norris |
22 March 2022
Drug Formulation
Discussion Group Report
This month, the discussion group debated the advantages and disadvantages of different types of inhalers. One key area of interest was current-day challenges with aerosol delivery, which could be addressed through smart inhalers and other innovative new devices.
By Oliver Picken |
17 March 2022
Inhaled Drug Delivery
Insight Article
How do we make the most of new techniques to optimise product development?
By Tom Cohen |
14 February 2022
Formulation & Delivery Series
Discussion Group Report
Beyond the blood–brain barrier, the pulmonary power of nebulisers, and RNA science in the post-COVID era
By Tom Cohen |
11 February 2022
RNA Formulation & Delivery
Insight Article
The pharmaceutical industry has historically taken a cautious approach to most new advancements, but now it is embracing the possibilities of continuous manufacturing technologies. While traditional batch-based processes are still more common, there are several products on the market that have utilized continuous manufacturing practices.
By Oliver Picken |
20 January 2022
Drug Formulation
Insight Article
RNA based therapeutics, particularly mRNA, has been experiencing a period of rapid growth, partly due to the influx of funding for mRNA Covid-19 Vaccines. One area that has the potential to benefit from mRNA vaccines is cancer. There are various techniques that have potential to combat the deadly disease.   
By Oliver Picken |
11 January 2022
RNA Formulation & Delivery
Discussion Group Report
This November, our Formulation Series discussion group focused on the formulation and delivery of inhaled biologics. Oxford Global’s discussion groups bring together a select group of 15-20 key industry leaders for approximately one hour for in depth knowledge sharing and conversation.
By Oliver Picken |
09 December 2021
Inhaled Drug Delivery
Insight Article
Nanomedicine and nanotechnology delivery systems are relatively new but have shown promising results and potential for innovative new drugs.
By Oliver Picken |
23 November 2021
Drug Delivery
Discussion Group Report
This September, our formulation series discussion group focused on the delivery of oral biologics. Biologic-based therapies have soared in popularity and now account for approximately 12% of the pharmaceutical market.
By Oliver Picken |
23 November 2021
Formulation & Delivery Series
Insight Article
In this Insight Article, we delve into the complex intricacies of the Blood-Brain Barrier, explore its challenge for drug delivery, and look at 3 of the most exciting solution technologies.
By Tia Byer |
01 October 2021
Drug Delivery
Insight Article
Can Inhaled Biologics make a comeback?  
By Oliver Picken |
30 September 2021
Inhaled Drug Delivery
Commentary
Exploring advancements in inhalation products with Peter J Barnes.
By Oliver Picken |
30 September 2021
Inhaled Drug Delivery
Commentary
Innovative drug delivery systems create a new paradigm for pharmaceuticals, enabling more efficient and targeted administration.
By Oliver Picken |
24 September 2021
Drug Delivery
Insight Article
In this Insight Article, we delve into the challenges of the gastrointestinal tract for oral peptide delivery and look at 3 of the most promising solution technologies
By Tia Byer |
15 September 2021
Inhaled Drug Delivery
Commentary
Drug Formulation and Delivery are changing rapidly, and the pace of change is expected to accelerate in the coming years
By Oliver Picken |
03 September 2021
Drug Formulation
Insight Article
Maya Thanou, Reader, King's College London
29 April 2019
Drug Delivery
Insight Article
Luis Padrela, Kevin M Ryan, Barry Long, Luis Padrela: Lecturer in Bioprocess Engineering, Bernal Institute; Kevin M Ryan: Chair in Chemical Nanotechnology, Bernal Institute; Barry Long: PhD student working in the design of supercritical fluid methods for the continuous manufacture of pharmaceutical nanocrystals, University of Limerick
29 April 2019
Drug Delivery
Advertisement

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login